Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer-Reference-Cited by-同舟云学术

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer

Published:2019-06-12 Issue:10 Volume:35 Page:1699-1710
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Goyal Ravi K.¹^ORCID,Carter Gebra Cuyun²,Nagar Saurabh P.¹,Smyth Emily N.²,Price Gregory L.²,Huang Yu-Jing²,Li Li²,Davis Keith L.¹,Kaye James A.³

Affiliation:

1. RTI Health Solutions, Research Triangle Park, Durham, NC, USA;

2. Eli Lilly and Company, Indianapolis, IN, USA;

3. RTI Health Solutions, Waltham, MA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1615422

Reference36 articles.

1. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

2. Projections of the Cost of Cancer Care in the United States: 2010-2020

3. Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

4. Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2011 [Internet]. Bethesda (MD): National Cancer Institute; 2014 [cited 2018 Dec 8]. Available from: http://seer.cancer.gov‌/csr‌/1975_2011/

5. Third consensus on medical treatment of metastatic breast cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of use and characterization of frailty assessments in observational studies on older women with breast cancer: a systematic review;BMC Geriatrics;2024-06-27

2. Social Determinants of Health and Other Predictors in Initiation of Treatment with CDK4/6 Inhibitors for HR+/HER2− Metastatic Breast Cancer;Cancers;2024-06-07

3. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors;Breast Cancer Research and Treatment;2024-01-08

4. Association Between Trajectories of Prescription Opioid Use and Risk of Opioid Use Disorder and Overdose Among US Nonmetastatic Breast Cancer Survivors;2023-03-21

5. Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2– metastatic breast cancer in the United States: A SEER‐Medicare population‐based study;Cancer;2023-02-09